{"id":7417,"date":"2022-04-26T20:09:34","date_gmt":"2022-04-26T20:09:34","guid":{"rendered":"http:\/\/hnetalk.com\/provider\/?p=7417"},"modified":"2022-04-26T20:09:34","modified_gmt":"2022-04-26T20:09:34","slug":"formulary-may-2022-update","status":"publish","type":"post","link":"http:\/\/hnetalk.com\/provider\/formulary-may-2022-update\/","title":{"rendered":"Formulary: May 2022 Update"},"content":{"rendered":"<p>Below is some important information regarding Spinraza and Zolgensma and our Commercial Members.<\/p>\n<p>Beginning May 27, 2022, Providers will continue to follow Health New England\u2019s process through Magellan, but Accredo Health Services will exclusively distribute Spinraza and Zolgensma. Once the approval has been obtained from Magellan, you may order the medication directly from Accredo at (866) 785-1557.<\/p>\n<p>As a reminder, Health New England\u2019s formularies are located at <a href=\"http:\/\/www.healthnewengland.org\" target=\"_blank\" rel=\"noopener\">healthnewengland.org<\/a>. At the top of the page, use the \u201cFind A Drug\u201d tool.<\/p>\n<p>For any questions or assistance needed, your Health New England Pharmacy team is available to help by calling (800) 842-4464. You may call your Provider Relations\u00a0Representative at (800) 842-4464, extension 5000, or send an email to <a href=\"mailto:providerrelations@hne.com\">providerrelations@hne.com<\/a>.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Below is some important information regarding Spinraza and Zolgensma and our Commercial Members. Beginning May 27, 2022, Providers will continue to follow Health New England\u2019s process through Magellan, but Accredo Health Services will exclusively distribute Spinraza and Zolgensma. Once the approval has been obtained from Magellan, you may order the medication directly from Accredo at [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"jetpack_post_was_ever_published":false,"_jetpack_newsletter_access":"","_jetpack_dont_email_post_to_subs":false,"_jetpack_newsletter_tier_id":0,"_jetpack_memberships_contains_paywalled_content":false,"_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2}},"categories":[92],"tags":[],"class_list":["post-7417","post","type-post","status-publish","format-standard","hentry","category-provider-newsletter"],"jetpack_publicize_connections":[],"jetpack_featured_media_url":"","jetpack_sharing_enabled":true,"jetpack_shortlink":"https:\/\/wp.me\/p6ZZHB-1VD","_links":{"self":[{"href":"http:\/\/hnetalk.com\/provider\/wp-json\/wp\/v2\/posts\/7417","targetHints":{"allow":["GET"]}}],"collection":[{"href":"http:\/\/hnetalk.com\/provider\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"http:\/\/hnetalk.com\/provider\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"http:\/\/hnetalk.com\/provider\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"http:\/\/hnetalk.com\/provider\/wp-json\/wp\/v2\/comments?post=7417"}],"version-history":[{"count":1,"href":"http:\/\/hnetalk.com\/provider\/wp-json\/wp\/v2\/posts\/7417\/revisions"}],"predecessor-version":[{"id":7418,"href":"http:\/\/hnetalk.com\/provider\/wp-json\/wp\/v2\/posts\/7417\/revisions\/7418"}],"wp:attachment":[{"href":"http:\/\/hnetalk.com\/provider\/wp-json\/wp\/v2\/media?parent=7417"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"http:\/\/hnetalk.com\/provider\/wp-json\/wp\/v2\/categories?post=7417"},{"taxonomy":"post_tag","embeddable":true,"href":"http:\/\/hnetalk.com\/provider\/wp-json\/wp\/v2\/tags?post=7417"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}